Discussion The majority of trials comparing coronary artery bypass grafting (CABG) and
medical therapy for patients with CSA were conducted in the 1970s and 1980s. The …

Ever since William Heberden's seminal description of angina pectoris in 1772, 1 attempts
have been made to find an effective treatment of this condition. Thomas Lauder Brunton was …

Background It has not been clearly established whether percutaneous coronary intervention
(PCI) can provide an incremental benefit in quality of life over that provided by optimal …

The 2019 annual meeting of the American Heart Association, which was held in
Philadelphia, was marked by considerable buzz around a presentation on the International …

Aims Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG)
perform similarly in terms of lowering mortality and myocardial infarction rates in patients …

A comment on this article appears in" Rebuttal: response to'Severe coronary disease not
amenable to revascularization--are the series clearly defined?'." Catheter Cardiovasc Interv …

Abstract The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
(COURAGE) trial has evoked renewed and intense discussion as to whether to recommend …

It is now half a century since the start of coronary bypass graft surgery (CABG) with the first
percutaneous coronary intervention (PCI) following just over a decade later. The relative …

Recent randomised controlled trials, such as ISCHEMIA and ORBITA, have overturned most
of what we were taught in medical school about hospital procedures considered necessary …

Coronary artery disease is a chronic medical condition associated with high mortality and
morbidity. Among individuals with coronary artery disease, more than 50% have chronic …